Jackson Square Capital’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-59,385
| Closed | -$913K | – | 142 |
|
|
2025
Q4 | $913K | Hold |
59,385
| – | – | 0.18% | 78 |
|
|
2025
Q3 | $590K | Hold |
59,385
| – | – | 0.13% | 93 |
|
|
2025
Q2 | $589K | Hold |
59,385
| – | – | 0.13% | 103 |
|
|
2025
Q1 | $770K | Buy |
59,385
+18,801
| +46% | +$249K | 0.25% | 76 |
|
|
2024
Q4 | $518K | Hold |
40,584
| – | – | 0.12% | 109 |
|
|
2024
Q3 | $452K | Hold |
40,584
| – | – | 0.11% | 107 |
|
|
2024
Q2 | $456K | Hold |
40,584
| – | – | 0.11% | 99 |
|
|
2024
Q1 | $504K | Hold |
40,584
| – | – | 0.13% | 101 |
|
|
2023
Q4 | $567K | Hold |
40,584
| – | – | 0.18% | 90 |
|
|
2023
Q3 | $599K | Hold |
40,584
| – | – | 0.24% | 68 |
|
|
2023
Q2 | $524K | Buy |
40,584
+24,220
| +148% | +$276K | 0.21% | 85 |
|
|
2023
Q1 | $161K | Hold |
16,364
| – | – | 0.07% | 105 |
|
|
2022
Q4 | $174K | Hold |
16,364
| – | – | 0.08% | 116 |
|
|
2022
Q3 | $171K | Buy |
+16,364
| New | +$213K | 0.08% | 118 |
|
|
2021
Q3 | – | Sell |
-80,400
| Closed | -$792K | – | 182 |
|
|
2021
Q2 | $792K | Hold |
80,400
| – | – | 0.25% | 84 |
|
|
2021
Q1 | $790K | Sell |
80,400
-42,155
| -34% | -$348K | 0.3% | 74 |
|
|
2020
Q4 | $545K | Hold |
122,555
| – | – | 0.21% | 79 |
|
|
2020
Q3 | $529K | Sell |
122,555
-50,000
| -29% | -$357K | 0.23% | 68 |
|
|
2020
Q2 | $1.53M | Sell |
172,555
-52,000
| -23% | -$263K | 0.77% | 44 |
|
|
2020
Q1 | $793K | Buy |
224,555
+81,375
| +57% | +$377K | 0.62% | 47 |
|
|
2019
Q4 | $819K | Buy |
+143,180
| New | +$766K | 0.47% | 63 |
|
Other funds holding DVAX
Jackson Square Capital's DVAX Position: Q1 2026 in Review
Jackson Square Capital sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 59,385 shares — an estimated $913K sold.
Jackson Square Capital first reported a position in DVAX in Q4 2019 and held it in 21 quarters. The position peaked at $1.53M in Q2 2020. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- Jackson Square Capital reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- Jackson Square Capital sold 59,385 Dynavax Technologies shares in Q1 2026, an estimated $913K.
- Jackson Square Capital first reported a position in Dynavax Technologies in Q4 2019 and held it in 21 quarters.
- Jackson Square Capital's Dynavax Technologies position peaked at $1.53M in Q2 2020.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on Jackson Square Capital's 13F filing for Q1 2026, filed 13 Apr 2026.